Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients
Hematological Oncology · 2025
DOI: 10.1002/hon.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, 2025. Verfasst von A Zduniak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Centre Henri Becquerel, Rouen, France. Hauptthemen laut MEDLINE: Lymphoma, Follicular, beta 2-Microglobulin, Tumor Burden. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We aimed to explore the predictive value of total metabolic tumor volume (TMTV) and beta‐2‐microglobulin (B2M) levels in patients with follicular lymphoma (FL) with a high tumor burden receiving standard first‐line immunochemotherapy. We analyzed 125 patients with the following characteristics: median age, 61 years (55; 67), advanced‐stage disease, 88.8%; high FLIPI, 49.6%; TMTV, > 510 cm 3 ; B2M, > 3 mg/L (24.8%); and R‐CHOP‐like treatment, 86.4%. We defined the following categories: low‐risk (36%), TMTV ≤ 510 cm 3 and B2M ≤ 3 mg/L; intermediate‐risk (45.6%), TMTV > 510 cm 3 or B2M > 3 mg/L; and high‐risk (18.4%), TMTV > 510 cm 3 and B2M > 3 mg/L. The 5‐year overall survival rates were estimated to be 96.1%, 89.1% and 73.7% for low‐, intermediate‐ and high‐risk patients, respectively ( p = 0.003). Patients at intermediate and high risk according to the TMTV/B2M score were at high risk of disease progression within 24 months of treatment initiation (HR = 2.45 [95% CI: 1.23–4.85] and HR = 3.75 [95% CI: 1.7–8.2], respectively). This TMTV/B2M score may identify patients with the highest unmet medical needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Centre Henri Becquerel, Rouen, France.
- Clinical Research Unit, Centre Henri Becquerel, Rouen, France.
- Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, France.
- QuantIF-LITIS (EA 4108-FR CNRS 3638), Faculty of Medicine, University of Rouen, Rouen, France.
- Inserm U1245, Centre Henri Becquerel, Université de Rouen, IRIB, Rouen, France.
ORCID-Profile: V Camus
Zitieren
APA
Zduniak, A., Lévêque, E., Draye-Carbonnier, S., Becker, S., Tonnelet, D., Dubois, S., Vera, P., Tilly, H., Jardin, F., Decazes, P., & Camus, V. (2025). Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients. Hematological Oncology. https://doi.org/10.1002/hon.70010
Vancouver
Zduniak A, Lévêque E, Draye-Carbonnier S, Becker S, Tonnelet D, Dubois S, et al. Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients. Hematological Oncology. 2025. doi:10.1002/hon.70010
BibTeX
@article{Zduniak2025,
author = {Zduniak, A and Lévêque, E and Draye-Carbonnier, S and Becker, S and Tonnelet, D and Dubois, S and Vera, P and Tilly, H and Jardin, F and Decazes, P and Camus, V},
title = {Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients},
journal = {Hematological Oncology},
year = {2025},
doi = {10.1002/hon.70010}
}
EUVIMED